Leuprolide Acetate Kit
Product Images NDC 71288-569

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 71288-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Fig A)

An instructional illustration showing a hand holding a syringe, positioned for subcutaneous injection. The image depicts proper handling of the syringe, likely related to the administration of a drug product.*

FDA Label Image

Figure B (Fig B)

Black and white illustration showing hands being washed under running water from a faucet. The image depicts thorough handwashing technique typically used for hygiene or preparation.*

FDA Label Image

Figure C (Fig C)

Black and white instructional illustration showing a hand removing the cap from a vial or bottle, likely demonstrating preparation for subcutaneous administration.*

FDA Label Image

Figure D (Fig D)

An instructional illustration showing a close-up of two hands handling a small medical device, possibly a subcutaneous injection pen or vial. The device is held between the thumb and forefinger, suggesting preparation for or demonstration of drug administration technique.*

FDA Label Image

Figure E (Fig E)

An instructional black and white illustration showing a hand holding a syringe with the thumb pushing the plunger, guiding an injection needle toward a target area, indicated by an arrow pointing to the right. The image demonstrates the technique for administering a subcutaneous injection, consistent with a kit dosage form.*

FDA Label Image

Figure F (Fig F)

An illustration showing a close-up of hands preparing a syringe by fitting the needle onto the syringe barrel, depicting a step in the subcutaneous injection process.*

FDA Label Image

Figure G (Fig G)

An instructional black and white illustration showing hands preparing a syringe by drawing liquid from a vial, likely related to the subcutaneous administration of Leuprolide Acetate. The image focuses on technique for medication preparation.*

FDA Label Image

Figure H (Fig H)

A black and white instructional illustration showing a close-up of two hands preparing a syringe by drawing liquid from a vial. The vial is held upside down while the syringe needle is inserted into the vial's rubber stopper, depicting a step in medication preparation.*

FDA Label Image

Figure I (Fig I)

An instructional illustration showing the use of a syringe to draw liquid medication from a vial. One hand holds the vial inverted while the other hand pulls back the syringe plunger to fill the syringe with the medication.*

FDA Label Image

Figure J (Fig J)

An instructional illustration showing a hand administering an injection using a syringe into the skin of the opposite hand, demonstrating subcutaneous injection technique relevant to Leuprolide Acetate kit use.*

FDA Label Image

Figure K (Fig K)

An instructional black-and-white illustration showing a hand holding a syringe for subcutaneous injection, with the other hand pinching the skin, demonstrating the proper technique for administering a subcutaneous injection.*

FDA Label Image

Figure L (Fig L)

An instructional black-and-white illustration showing a hand disposing of a syringe into a labeled sharps container, demonstrating safe disposal of injectable medication needles.*

FDA Label Image

Package Label.principal Display Panel Leuprolide Acetate Injection Carton (Leup Carton)

Packaging label for Leuprolide Acetate Injection 14 mg per 2.8 mL (1 mg per 0.2 mL) subcutaneous injection kit. The label shows a multiple-dose vial of 2.8 mL sterile injection intended for subcutaneous use. Labeler is Meitheal Pharmaceuticals Inc. The carton includes usage and storage information, ingredients, barcodes, and manufacturing details.*

FDA Label Image

Package Label.principal Display Panel Leuprolide Acetate Injection Kit (Leup Kit)

Packaging label for Leuprolide Acetate Injection 14 mg per 2.8 mL (1 mg per 0.2 mL) kit for subcutaneous injection. The 14-day patient administration kit is labeled for prescription use only and manufactured by Meitheal Pharmaceuticals Inc. The carton provides dosage, storage information, and manufacturing details including a barcode and NDC 71288-569-90.*

FDA Label Image

Structure (Leup Structure)

Chemical structure diagram of leuprolide acetate showing its molecular backbone and side chains, consistent with the active ingredient leuprolide acetate.*

FDA Label Image

Package Label.principal Display Panel Leuprolide Acetate Injection Vial Label (Leup Vial)

Leuprolide Acetate Injection 14 mg per 2.8 mL (1 mg per 0.2 mL) dosage label for a 2.8 mL multiple-dose vial. The label includes administration instructions for subcutaneous injection, storage conditions to protect from light, and manufacturer information for Meitheal Pharmaceuticals Inc, Chicago, IL. The vial is intended for subcutaneous use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.